1. Home
  2. TNXP vs GAIA Comparison

TNXP vs GAIA Comparison

Compare TNXP & GAIA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TNXP
  • GAIA
  • Stock Information
  • Founded
  • TNXP 2007
  • GAIA 1988
  • Country
  • TNXP United States
  • GAIA United States
  • Employees
  • TNXP N/A
  • GAIA N/A
  • Industry
  • TNXP Biotechnology: Pharmaceutical Preparations
  • GAIA Movies/Entertainment
  • Sector
  • TNXP Health Care
  • GAIA Consumer Discretionary
  • Exchange
  • TNXP Nasdaq
  • GAIA Nasdaq
  • Market Cap
  • TNXP 116.9M
  • GAIA 104.1M
  • IPO Year
  • TNXP N/A
  • GAIA 1999
  • Fundamental
  • Price
  • TNXP $15.71
  • GAIA $3.89
  • Analyst Decision
  • TNXP Strong Buy
  • GAIA Strong Buy
  • Analyst Count
  • TNXP 2
  • GAIA 2
  • Target Price
  • TNXP $585.00
  • GAIA $8.00
  • AVG Volume (30 Days)
  • TNXP 1.5M
  • GAIA 40.7K
  • Earning Date
  • TNXP 05-12-2025
  • GAIA 05-05-2025
  • Dividend Yield
  • TNXP N/A
  • GAIA N/A
  • EPS Growth
  • TNXP N/A
  • GAIA N/A
  • EPS
  • TNXP N/A
  • GAIA N/A
  • Revenue
  • TNXP $10,094,000.00
  • GAIA $90,363,000.00
  • Revenue This Year
  • TNXP $12.17
  • GAIA $14.66
  • Revenue Next Year
  • TNXP $789.15
  • GAIA $16.14
  • P/E Ratio
  • TNXP N/A
  • GAIA N/A
  • Revenue Growth
  • TNXP 29.94
  • GAIA 12.36
  • 52 Week Low
  • TNXP $6.76
  • GAIA $2.93
  • 52 Week High
  • TNXP $672.00
  • GAIA $6.53
  • Technical
  • Relative Strength Index (RSI)
  • TNXP 44.80
  • GAIA 51.12
  • Support Level
  • TNXP $15.23
  • GAIA $2.99
  • Resistance Level
  • TNXP $22.25
  • GAIA $4.13
  • Average True Range (ATR)
  • TNXP 2.36
  • GAIA 0.32
  • MACD
  • TNXP -0.54
  • GAIA 0.08
  • Stochastic Oscillator
  • TNXP 16.54
  • GAIA 80.00

About TNXP Tonix Pharmaceuticals Holding Corp.

Tonix Pharmaceuticals Holding Corp is a biopharmaceutical company focused on developing, licensing and commercializing therapeutics to treat and prevent human disease and alleviate suffering. Tonix's development portfolio is focused on central nervous system (CNS) disorders. The company's immunology development portfolio consists of biologics to address organ transplant rejection, autoimmunity and cancer, including TNX-1500, which is a humanized monoclonal antibody targeting CD40-ligand (CD40L or CD154) being developed for the prevention of allograft rejection and for the treatment of autoimmune diseases. Tonix also has product candidates in development in the areas of rare disease and infectious disease.

About GAIA Gaia Inc.

Gaia Inc is a video streaming service and community that provides curated conscious media in primary channels; Seeking Truth provides new and enlightening perspectives for today's changing world; Transformation provides a wealth of content in the niche areas of spiritual growth, personal development, and expanded consciousness; Alternative Healing channel features content focused on food and nutrition, holistic healing, alternative and integrative medicines, and longevity, and Yoga. Geographically, it derives a majority of its revenue from the United States and also has an International presence.

Share on Social Networks: